Aleva Neurotherapeutics SA
Aleva Neurotherapeutics has developed a high resolution neurostimulation platform that delivers therapy with high selectivity. Aleva Neurotherapeutics develops the next generation of Directional Deep Brain Stimulation systems based on MEMS technology. Our unique microfabricated devices enable Target Specific Stimulation and optimization of current therapies. The first application is in Deep Brain Stimulation for indications such as Parkinson`s Disease and Essential Tremor. Aleva was founded in 2008 as a spin-off of the Swiss Federal Institute of Technology in Lausanne, Switzerland.
Company details
Find locations served, office locations
- Business Type:
- Manufacturer
- Industry Type:
- Medical Equipment
- Market Focus:
- Internationally (various countries)
- Year Founded:
- 2008